Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1672Source: DataRank Database

Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 88 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access88 citations

Download PDF

Cite:

Linked data & code

cellosaurus rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.81)OA: greenTopics (33)Linked Datasets (18)DataCite Reuse (18)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Alexandra Redding ORCID,Hannah Hoag-Lee ORCID,Edward S. Sim ORCID,Stefan Heinrich ORCID,Matthias M. Gaida ORCID

Live enrichment

PubMed:35674408 PMC:PMC9357213 OpenAlex:https://openalex.org/W4282946314

NIH NCI

Grant: R37CA230645

German Research Foundation

Grant: Ga 1818/2-3

German Research Foundation

Grant: SFB1292

National Cancer Center

Grant: P30 CA056036

NCI NIH HHS

Grant: R01 CA160495

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R37CA230645-05

Stress-adaptation in obesity-associated pancreatic cancer

National Institutes of Health

Grant: 3P30CA056036-22S1

Strengthening Community Engagement in Colorectal Cancer Screening and Clinical Trial Enrollment Through a Community Health Educator

National Institutes of Health

Grant: 5R01CA160495-08

FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma

FWCI

5.81

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9357213

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-21-1672/3155574/cd-21-1672.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-21-1672/3180485/cd-21-1672.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/12/8/1984/3238523/1984.pdf

Fields of Study

RNA Research and SplicingEndoplasmic Reticulum Stress and DiseaseFerroptosis and cancer prognosis0301 basic medicine0303 health sciences03 medical and health sciencesCarcinoma, Pancreatic DuctalHumansObesityPancreatic NeoplasmsProtein Serine-Threonine KinasesStress Granules

MeSH Terms

Stress GranulesHumansObesityPancreatic NeoplasmsProtein Serine-Threonine KinasesCarcinoma, Pancreatic Ductal

Keywords

Pancreatic cancerObesityCancerMedicineInternal medicineBioinformaticsBiologyCancer researchEndocrinologyComputational biologyPancreatic NeoplasmsHumansProtein Serine-Threonine KinasesStress GranulesCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

10.6084/m9.figshare.25010468.v1figshare

Additional file 1 of SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

10.6084/m9.figshare.25010468figshare

Additional file 7 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643409.v1figshare

Additional file 7 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643409figshare

Additional file 8 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643412.v1figshare

Additional file 8 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643412figshare

Additional file 6 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643406.v1figshare

Additional file 6 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643406figshare

Additional file 4 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643400.v1figshare

Additional file 5 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643403.v1figshare

Additional file 4 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643400figshare

Additional file 5 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643403figshare

Additional file 3 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643397figshare

Additional file 2 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643394figshare

Additional file 3 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643397.v1figshare

Additional file 1 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643391.v1figshare

Additional file 2 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643394.v1figshare

Additional file 1 of LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability

10.6084/m9.figshare.26643391figshare